A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCB01-0371 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2014
At a glance
- Drugs LCB01-0371 (Primary) ; Linezolid
- Indications Bacterial infections
- Focus Adverse reactions
- Sponsors LegoChem Biosciences
- 10 Dec 2014 Last checked against ClinicalTrials.gov record.
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2012 New trial record